Clinical trial
A Phase 1 Study of MORAb-009 in Patients With Solid Tumor
NCT01018784 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of MORAb-009 in Patients With Solid Tumor
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- February 28, 2013
- Enrollment
- 17 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, mesothelin-positive